On Friday, the White House confirmed that President Trump is being treated for coronavirus with “polyclonal antibodies.”
According to the New York Post:
Dr. Sean Conley, physician to the president, released Trump’s course of treatment in a public memo following Trump’s early-morning disclosure on Twitter.
“Following PCR-confirmation of the President’s diagnosis, as a precautionary measure he received a single 8 gram dose of Regeneron’s polyclonal antibody cocktail,” Conley wrote.
The treatment has shown preliminary effectiveness in reducing the viral load and symptoms of people infected by the coronavirus by making their body better able to fight off the virus.
“He completed the infusion without incident,” Conley wrote.
“In addition to the polyclonal antibodies, the president has been taking zinc, vitamin D, famotidine [an antacid], melatonin and a daily aspirin,” according to the memo.
An update from President @realDonaldTrump's physician: pic.twitter.com/cTsXO4Df6b
— Kayleigh McEnany 45 Archived (@PressSec45) October 2, 2020
The Post continues:
Conley wrote that “[a]s of this afternoon the President remains fatigued but in good spirits. He’s being evaluated by a team of experts, and together we’ll be making recommendations to the President and First Lady in regards to next best steps.”
First lady Melania Trump, who also tested positive for the virus, “remains well with only a mild cough and headache, and the remainder of the First Family are well and tested negative,” Conley said.
The Washington Examiner reports as well:
Regeneron Pharmaceuticals developed the treatment, which contains two potent antibodies against the coronavirus spike protein.
Early study results indicate that the antibody cocktail may help treat coronavirus symptoms by reducing the viral load.
In one early trial of 275 coronavirus patients, those who received the treatment had lower virus levels in their bloodstream after one week compared with those who were given a placebo, according to the company.
“The greatest treatment benefit was in patients who had not mounted their own effective immune response,” George Yancopoulos, Regeneron’s chief scientific officer, said in a statement announcing the results on Tuesday.
We pray that the President and First Lady have a quick and healthy recovery.
